The Latest in Multiple Sclerosis

Clinical Neurology News

BENEFIT 11: No new safety signals with interferon beta-1b

March 2, 2016

Multiple Sclerosis

Clinical Neurology News

Study examines efficacy of small group programs for fatigue in MS

March 2, 2016

Multiple Sclerosis

Neurology Reviews

L-Selectin May Not Predict PML Risk Accurately

February 29, 2016

Multiple Sclerosis

Neurology Reviews

Proposal Requires Three Lesions for Diagnosis of MS

February 29, 2016

Multiple Sclerosis

Neurology Reviews

Phenytoin May Offer Neuroprotection to Patients With Optic Neuritis

February 29, 2016

Multiple Sclerosis

Neurology Reviews

Natalizumab May Increase Risk of JCV Seroconversion

February 29, 2016

Multiple Sclerosis

Clinical Neurology News

Stem cell therapy for MS: Steady progress but not ready for general use

February 28, 2016

Multiple Sclerosis

Clinical Neurology News

Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMS

February 26, 2016

Multiple Sclerosis

Clinical Neurology News

Triage MS-related ED visits to reduce unnecessary treatment

February 26, 2016

Multiple Sclerosis

Clinical Neurology News

Fingolimod improved gait impairment in small study

February 26, 2016

Multiple Sclerosis

Clinical Neurology News

VIDEO: Novel tools measure disease progression in MS

February 25, 2016

Multiple Sclerosis

Clinical Neurology News

Positive headway reported for progressive multiple sclerosis

February 25, 2016

Multiple Sclerosis

Clinical Neurology News

VIDEO: MS stem cell therapy research progresses, including oligodendrocyte progenitor trial

February 24, 2016

Multiple Sclerosis

Clinical Neurology News

Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions

February 24, 2016

Multiple Sclerosis

Clinical Neurology News

Blood-borne biomarkers of MS relapse identified

February 24, 2016

Multiple Sclerosis